Home

Important Product Safety Information

Optimark™

Important Safety Alert regarding Coeur, Inc. disposable 125 mL syringe used in Optivantage™ DH Contrast Media Injector

Click here to view Mallinckrodt Coeur syringe alert.

Mallinckrodt's Methylphenidate Hydrochloride Extended-Release Tablets, USP

Click here for full prescribing information.

Mallinckrodt’s Position on Safe and Effective Use of Opioids

Click here for Mallinckrodt’s Position on Safe and Effective Use of Opioids

Voluntary recall issued for Coiled Tubing

Click here for the Coiled Tubing Recall Letter 2-10-12

Voluntary recall issued for Disposable Magnetic Resonance Syringes/Tubing

Click here for the Disposable MR Tubing and Syringes Recall Letter 2-10-12
Featured Products

PENNSAID® (diclofenac sodium topical solution) 1.5% w/w
Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information

EXALGO® (hydromorphone HCl) Extended-Release Tablets, CII 8 mg
Click Product for Boxed Warning and U.S. Full Prescribing Information Link for Additional Important Risk Information

Ultra-Technekow™ DTE

News & Press

Archives

Pharmaceutical Products

03/25/2013 8:47 AM

Mallinckrodt Launches Additional Dosage Strengths of Generic CONCERTA® in U.S.

36 and 54 milligram dosage strengths of ADHD treatment now available ST LOUIS--(BUSINESS WIRE)--Mar 25, 2013-- Mallinckrodt, the Pharmaceuticals business of Covidien (NYSE: COV), today announced that it launched the 36 and 54 milligram (mg) dosage strengths of ...

Imaging Products

02/13/2013 3:05 AM

Mallinckrodt Medical BV will promote and distribute Rapiscan® (regadenoson) in France, Italy, Belgium, and Spain

February 11, 2013, London – Today Rapidscan Pharma Solutions (RPS) EU Ltd announced that they have come to agreement with Mallinckrodt Medical BV (Mallinckrodt) for the exclusive right to promote and distribute Rapiscan® (regadenoson) in France, Italy, Belgium and Spain Rapiscan is a sele...

Covidien

05/20/2013 9:19 AM

Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims

Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo--(BUSINESS WIRE)--May 20, 2013-- Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory car...

05/20/2013 9:18 AM

Covidien Announces Pricing of $750 Million Senior Notes Offering

DUBLIN--(BUSINESS WIRE)--May 13, 2013-- Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance SA (CIFSA), priced an underwritten offering of $750 million aggregate principal amount of 2950% senior notes due 2023 Th...

Important Product Safety Information

Featured Products

News & Press

Pharmaceutical Products

Imaging Products

Covidien